Format
Sort by

Send to:

Choose Destination

Search results

Items: 5

1.

Tissue-Specific Suppression of Thyroid Hormone Signaling in Various Mouse Models of Aging.

Visser WE, Bombardieri CR, Zevenbergen C, Barnhoorn S, Ottaviani A, van der Pluijm I, Brandt R, Kaptein E, van Heerebeek R, van Toor H, Garinis GA, Peeters RP, Medici M, van Ham W, Vermeij WP, de Waard MC, de Krijger RR, Boelen A, Kwakkel J, Kopchick JJ, List EO, Melis JP, Darras VM, Dollé ME, van der Horst GT, Hoeijmakers JH, Visser TJ.

PLoS One. 2016 Mar 8;11(3):e0149941. doi: 10.1371/journal.pone.0149941. eCollection 2016.

2.

Glucocorticoid sensitivity in Behçet's disease.

Quax RA, van Laar JA, van Heerebeek R, Greiner K, Ben-Chetrit E, Stanford M, Wallace GR, Fortune F, Ghabra M, Soylu M, Hazes JM, Lamberts SW, Kappen JH, van Hagen PM, Koper JW, Feelders RA.

Endocr Connect. 2012 Oct 24;1(2):103-11. doi: 10.1530/EC-12-0056. Print 2012 Nov 1.

3.

In vitro glucocorticoid sensitivity is associated with clinical glucocorticoid therapy outcome in rheumatoid arthritis.

Quax RA, Koper JW, de Jong PH, van Heerebeek R, Weel AE, Huisman AM, van Zeben D, de Jong FH, Lamberts SW, Hazes JM, Feelders RA.

Arthritis Res Ther. 2012 Aug 24;14(4):R195. doi: 10.1186/ar4029.

4.

Clinical phenotype and mutant TRα1.

van Mullem A, van Heerebeek R, Chrysis D, Visser E, Medici M, Andrikoula M, Tsatsoulis A, Peeters R, Visser TJ.

N Engl J Med. 2012 Apr 12;366(15):1451-3. doi: 10.1056/NEJMc1113940. No abstract available.

5.

Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.

Feelders RA, de Bruin C, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, van Heerebeek R, de Jong FH, van der Lely AJ, de Herder WW, Hofland LJ, Lamberts SW.

N Engl J Med. 2010 May 13;362(19):1846-8. doi: 10.1056/NEJMc1000094. No abstract available.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk